Paracetamol is used by millions of people to relieve pain and reduce fever. Yet we still do not fully understand how it works in the brain. This project investigates how paracetamol affects brain function and cognitive processes.
About the project
Paracetamol is one of the most widely used over-the-counter medicines worldwide. Its pain-relieving and fever-reducing effects are well established, but questions remain about its mechanisms of action and how it affects other aspects of brain function.
We are investigating the neurocognitive effects of paracetamol in a randomised, double-blind, placebo-controlled trial. Participants are randomly assigned to receive either paracetamol or a placebo, a preparation with no active ingredient. Neither the participants nor the researchers assessing the effects know which treatment each participant receives.
The study aims to improve our understanding of how this widely used medicine affects the brain.
Project end year: 2032
EU project number: 2025-522753-19-02
Project team at OsloMet
- Eva Hilland, Associate Professor and Project Leader
- Shervin Bukhari, PhD Research Fellow
- Rune Jonassen
- Hege Smith Tunsjø
- Brage Kraft
- Ying Chen
- Liana Gukasyan
External project participants
- Hasse Khiabani Zaré, MD, PhD, Senior Consultant and Specialist in Clinical Pharmacology, Clinical Research Unit, Oslo University Hospital
- Pia Regina Nøsterberget, Nurse, Clinical Research Unit, Oslo University Hospital
- Martin Paulus, MD, PhD, Laureate Institute for Brain Research (LIBR), USA
Collaborating institutions
- Oslo University Hospital, Norway
- Fürst Medisinsk Laboratorium, Norway
- Laureate Institute for Brain Research (LIBR), USA
Contact
For questions about the project, please contact:
Eva Hilland, Associate Professor and Project Leader
Email: eva.hilland@oslomet.no
Telephone: +47 95019572
Shervin Bukhari, PhD Research Fellow
Email: shervin.bukhari@oslomet.no